RedHeaderRight1

Current Articles | Archives | Search

Thursday, March 2, 2017
Intalere Members Benefit from New Agreement with NOVADAQ
By @ 11:40 AM :: 1976 Views :: Article Rating :: Agreements
 

Intalere Members Benefit from New Agreement with NOVADAQ

Contact: Evan Danis
  Sr. Director, Corporate Communications
724-778-3423
evan.danis@intalere.com

St. Louis (March 2, 2017) – Intalere, the healthcare industry leader in delivering optimal cost, quality and clinical outcomes, announces a new agreement with NOVADAQ.

Through this agreement Intalere members will receive competitive pricing on the SPY Elite® Fluorescence Imaging System (and its consumable Kits)and Dermacell biological mesh (human tissue matrix allograft). SPY Elite® is the first and most advanced fluorescence imaging system that provides images that may assist surgeons in making critical decisions in the operating room. SPY Elite® has been shown to reduce rates of postoperative complications and decrease healthcare costs. Recent findings demonstrate that the use of Dermacell ADM in immediate breast reconstruction has demonstrated statistically significant improvements in number of days to drain removal and incidence rates of red breast syndrome.  

This contract is currently effective through January 31, 2019. 

About NOVADAQ Technologies Inc.
NOVADAQ’s global mission is to enable physicians with point-of-care imaging solutions that provide real-time clinically significant and actionable information to improve care quality and lower healthcare costs. Using NOVADAQ’s SPY fluorescence imaging technology, physicians can personalize therapy and achieve optimal results through the precise visualization of blood flow in vessels, micro-vessels, tissue perfusion and critical anatomical structures during the course of treatment. SPY technology enables the delivery of personalized therapies and the achievement of the optimal results for each individual patient. More than 225 peer-reviewed publications demonstrate that the use of SPY technology will reduce post-procedure complication rates and the cost of care for a broad variety of surgical treatments for cancer, cardiovascular diseases and other conditions, helping to ensure that patients benefit from the very best possible treatment and outcome.  

About Intalere
Intalere’s mission focuses on improving the operational health of America’s healthcare providers by designing tailored, smart solutions that deliver optimal cost, quality and clinical outcomes. We strive to be the essential partner for operational excellence in healthcare through customized solutions that address customers’ individual needs. We assist our customers in managing their entire spend, providing innovative technologies, products and services, and leveraging the best practices of a provider-led model. As Intalere draws on the power of our owner Intermountain Healthcare’s nationally-recognized supply chain expertise and leadership in technology, process improvement, and evidence-based clinical and business best practices, we are uniquely positioned to be the innovation leader in the healthcare industry. Visit www.intalere.com to learn more.

Rating
Comments

Illuminated-Path-Podcast-Support

Illuminated Path Podcast Series

Listen to healthcare leaders, thinkers and innovators lead enriching discussions about industry best practices related to elevating clinical, operational and financial performance.

Listen now


News

Newsroom

Intalere News Coverage

Intalere Blog

Press Releases

New Intalere Agreements

White Papers

Industry Experts

Event Calendar


Recent Blog Posts

Visit Our Blog